home
College of Arts and Sciences

Department of Psychology

Sarah Heil

Human Behavioral Pharmacology

Sarah Heil

Sarah Heil
Research Associate Professor of Psychology
Research Associate Professor of Psychiatry

Education
  • B.A. Wittenberg University, 1992
  • Ph.D. Dartmouth College, 1997
C.V. (PDF)
Email: sarah.heil@uvm.edu
Phone: (802) 656-8714
Room: FAHC-UHC Room 1415

Duties
Faculty, Substance Abuse Treatment Center
Faculty, Human Behavioral Pharmacology Laboratory
Faculty, Behavioral Pharmacology of Drug Dependence Training Program

Areas
Drug abuse treatments for pregnant and postpartum women, including behavioral treatments such as contingency management and pharmacological treatments such as opioid replacement therapies.

Facilities

Human Behavioral Pharmacology Laboratory (HBPL): This facility of 6,000 sq. ft., is located adjacent to the University of Vermont (UVM) campus in Burlington and is the site for laboratory research in drug self-administration, drug discrimination, and the direct effects of drugs and for treatment studies for smoking cessation.

Substance Abuse Treatment Center (SATC): This facility of 2,900 sq. ft., is also located adjacent to the UVM campus, and is our site for the development and testing of scientifically-based behavioral and pharmacological treatments for cocaine and opioid dependence as well as smoking cessation for pregnant women. For addtional information on the Substance Abuse Treatment Center3.

Accepting Students Fall 2013
Professor Heil is potentially accepting students who enter the program in the Fall of 2013.

Representative Publications

  • Heil, S.H., Gaalema, D.E., Johnston, A.M., Sigmon, S.C., Badger, G.J., & Higgins, S.T. (2012). Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: A feasibility study. Drug and Alcohol Dependence, 126, 268-271.
  • Heil, S.H., Gaalema, D.E., & Herrmann, E.S. (2012). Incentives to promote family planning. Preventive Medicine, 55, Suppl 1, S106-112.
  • Gaalema, D.E., Linares Scott, T., Heil, S.H., Coyle, M., Kaltenbach, K., Stine, S., Martin, P., & Jones, H. (2012). Differences in the profile of neonatal abstinence syndrome signs in methadone- vs. buprenorphine-exposed neonates. Addiction, 107, Suppl 1, 53-62.
  • Heil, S.H., Jones, H.E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., Stine, S., Selby, P., & Martin, P. R. (2011). Unintended pregnancy in opioid-abusing women. Journal of Substance Abuse Treatment, 40, 199-202.
  • Jones, H.E., Kaltenbach, K., Heil, S.H., Stine, S.M., Coyle, M.G., Arria, A.M., O’Grady, K.E., Selby, P., Martin, P.R., & Fischer, G. (2010). Neonatal abstinence syndrome following methadone or buprenorphine exposure. New England Journal of Medicine, 363, 2320-2331.
  • Higgins, S.T., Bernstein, I.M., Washio, Y., Heil, S.H., Badger, G.J., Skelly, J.M., Higgins, T.M., & Solomon, L.J. (2010). Effects of smoking cessation with voucher-based contingency management on birth outcomes. Addiction, 105, 2023-2030.
  • Heil, S.H., Higgins, S.T., Bernstein, I.M., Solomon, L.J., Rogers, R.E., Thomas, C.S., Badger, G.J., & Lynch, M.E. (2008). Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction, 108, 1009-1018.
Contact UVM © 2013 The University of Vermont - Burlington, VT 05405 - (802) 656-3131